A Study to Compare Two Different Formulations of Lasmiditan in Healthy Participants

NCT04881747 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

47

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Lasmiditan

Sponsor

Eli Lilly and Company